HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Tefferi Selected Research

Abnormal Karyotype

10/2017Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations.
11/2015Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.
9/2013Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Tefferi Research Topics

Disease

39Primary Myelofibrosis (Myelosclerosis)
01/2018 - 01/2000
16Neoplasms (Cancer)
01/2017 - 08/2001
14Polycythemia Vera
03/2015 - 07/2000
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 08/2000
13Essential Thrombocythemia
03/2015 - 08/2000
10Splenomegaly
10/2017 - 01/2000
9Thrombocytosis (Thrombocythemia)
03/2016 - 01/2000
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2016 - 10/2000
7Systemic Mastocytosis
04/2016 - 01/2001
6Thrombosis (Thrombus)
10/2017 - 09/2001
6Anemia
11/2015 - 09/2000
6Leukemia
04/2012 - 01/2000
5Thrombocytopenia (Thrombopenia)
06/2013 - 06/2002
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2011 - 01/2000
4Fibrosis (Cirrhosis)
10/2017 - 11/2000
4Leukocytosis (Pleocytosis)
10/2017 - 01/2001
4Eosinophilia
01/2015 - 05/2004
4Lymphoma (Lymphomas)
04/2012 - 02/2000
4Polycythemia (Erythrocytosis)
05/2009 - 07/2000
4Myeloproliferative Disorders (Myeloproliferative Disorder)
09/2008 - 01/2005
4Multiple Myeloma
01/2005 - 07/2000
4Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2003 - 09/2000
3Abnormal Karyotype
10/2017 - 09/2013
3Hematologic Neoplasms (Hematological Malignancy)
04/2016 - 05/2003
3Hemorrhage
04/2012 - 06/2002
3Blast Crisis (Blast Phase)
03/2012 - 01/2000
3Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2006 - 08/2001
3Graft vs Host Disease (Graft-Versus-Host Disease)
08/2002 - 06/2001
3Iron Deficiencies
12/2001 - 01/2000
3Spontaneous Abortion (Miscarriage)
09/2001 - 01/2001
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2015 - 06/2006
2Chronic Neutrophilic Leukemia
06/2014 - 09/2013
2Mastocytosis
06/2013 - 05/2004
2Acute Erythroblastic Leukemia (Erythroleukemia)
08/2009 - 06/2006
2Disease Progression
09/2007 - 07/2001
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2006 - 08/2001
2Amyloidosis
12/2004 - 11/2000
2Mucositis
08/2002 - 06/2001
2Pruritus (Itching)
12/2001 - 01/2000
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2001 - 11/2001
2Bronchiolitis Obliterans
09/2001 - 07/2001
2Hepatomegaly
09/2001 - 01/2001
2Bronchiolitis Obliterans Syndrome
07/2001 - 06/2001
2Cytopenia
01/2001 - 04/2000
1Neutropenia
01/2017
1Refractory Anemia
03/2016
1Wernicke Encephalopathy (Wernicke's Encephalopathy)
08/2015

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
01/2015 - 02/2001
8DNA (Deoxyribonucleic Acid)IBA
04/2016 - 06/2006
6N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
01/2018 - 08/2009
6Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2014 - 06/2010
6CytokinesIBA
06/2013 - 10/2000
6Imatinib Mesylate (Gleevec)FDA Link
02/2011 - 08/2003
5ErythropoietinFDA Link
08/2009 - 01/2001
5Hydroxyurea (Hydrea)FDA LinkGeneric
11/2001 - 01/2000
4Reticulin (Reticular Fiber)IBA
10/2017 - 11/2000
4fedratinibIBA
08/2015 - 09/2008
4ruxolitinibIBA
02/2015 - 02/2011
4Janus Kinase InhibitorsIBA
12/2014 - 02/2011
4Hemoglobins (Hemoglobin)IBA
10/2014 - 11/2000
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2012 - 01/2000
4Phosphotransferases (Kinase)IBA
08/2009 - 01/2000
3pomalidomideIBA
01/2017 - 02/2011
3anagrelide (Agrylin)FDA LinkGeneric
11/2015 - 01/2000
3CalreticulinIBA
12/2014 - 07/2014
3Prednisone (Sone)FDA LinkGeneric
02/2011 - 06/2001
3Janus Kinase 2IBA
06/2010 - 10/2006
3CladribineFDA LinkGeneric
02/2004 - 01/2001
3Inosine Triphosphate (ITP)IBA
12/2003 - 09/2000
3Methotrexate (Mexate)FDA LinkGeneric
08/2002 - 02/2000
2Busulfan (Busulfex)FDA Link
01/2016 - 11/2015
2Janus KinasesIBA
12/2014 - 02/2011
2EnzymesIBA
04/2012 - 09/2011
2IronIBA
08/2009 - 03/2001
2tipifarnib (R115777)IBA
09/2007 - 05/2003
2Lenalidomide (CC 5013)FDA Link
08/2007 - 11/2006
2Growth Factor ReceptorsIBA
07/2007 - 01/2005
2Melphalan (Alkeran)FDA LinkGeneric
01/2005 - 12/2004
2Interferon-alpha (Interferon Alfa)IBA
02/2004 - 03/2001
2Proteins (Proteins, Gene)FDA Link
11/2001 - 02/2000
2Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2001 - 06/2001
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2001 - 10/2000
2Thrombopoietin ReceptorsIBA
09/2000 - 07/2000
1Core Binding Factors (Core-Binding Factor)IBA
01/2022
1Azacitidine (5 Azacytidine)FDA Link
04/2016
1MethyltransferasesIBA
04/2016
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
04/2016
1cc-486IBA
04/2016
1imetelstatIBA
03/2016
1Pipobroman (Vercyte)FDA Link
11/2015
1DepsipeptidesIBA
03/2015

Therapy/Procedure

22Therapeutics
01/2017 - 02/2000
8Stem Cell Transplantation
11/2015 - 07/2000
7Hematopoietic Stem Cell Transplantation
06/2006 - 06/2001
6Drug Therapy (Chemotherapy)
01/2022 - 01/2001
5Splenectomy
09/2010 - 04/2000
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2003 - 07/2001
3Transplantation
09/2003 - 11/2000
2Radiotherapy
09/2010 - 01/2001
2Operative Surgical Procedures
09/2001 - 09/2000